OPDIVO, as a single agent, is indicated with the treatment of adult and pediatric patients twelve years of age and more mature with unresectable or metastatic melanoma.If deprived of oxygen, the cells shrink and reduce contact with each other, forcing the electrical communications among the cells to are unsuccessful.Similarly, patients who put up w